期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

视网膜静脉阻塞继发黄斑水肿的抗VEGF药物治疗进展 被引量：32

Research progress on anti-VEGF drugs for macular edema secondary to retinal vein occlusion
在线阅读 下载PDF
导出
摘要 视网膜静脉阻塞是一种常见的眼科疾病,黄斑水肿是其重要临床表现,对视力有重要损害。血管内皮生长因子(vascular endothelial growth factor,VEGF)在视网膜静脉阻塞继发黄斑水肿形成中可能具有重要作用,因此,抗VEGF药物的应用,提供了新的治疗手段,雷珠单抗、贝伐单抗、阿柏西普、康柏西普是临床上用于玻璃体内注射的主要抗VEGF药物,本文就各种抗VEGF药物的临床疗效作一综述。 Retinal vein occlusion（ RVO） is a common disease. Macular edema is the important performance which leads to server visual loss. Vascular endothelial growth factor （VEGF） plays an important role in the development of RVO. The application of anti-VEGF drugs provides a new method for the treatment of macular edema. Ranibi- zumab, aflibercept, eonbercept are the main types of the anti-VEGF drugs, which are used for clinical treatment. This article reviews the clinical effects of various anti-VEGF drugs.
作者 夏松 陈有信
机构地区 中国医学科学院北京协和医院
出处 《眼科新进展》 CAS 北大核心 2016年第11期1093-1096,共4页 Recent Advances in Ophthalmology
关键词 视网膜静脉阻塞 黄斑水肿 血管内皮生长因子 抗血管内皮生长因子 retinal vein occlusion macular edema vascular endothelial growthfactor anti vascular endothelial growth factor
分类号 R774.1 [医药卫生—眼科]
作者简介 夏松，男，1990年4月出生，在读硕士研究生。联系电话：18510031342：E-mail：xs1342@126．com；ORCID：0000-0002-6010-0797 通讯作者：陈有信，E—mail：chenyoux—inpumch@163．com；ORCID：0000—0001-7175-8183
  • 相关文献

参考文献43

  • 1HAYREH SS. Retinal vein occlusion[ J]. Indian J Ophthal-mo/,1994,42(3) : 109-132.
  • 2COSCAS G,GAUDRIC A. Natural course of nonaphakic cys-toid macular edema[ J ]. Surv Ophthalmol,1984,28 (suppl):471484.
  • 3CAMPOCHIARO PA. Retinal and choroidal neovascularization[J].JCell Physiol,2000,184(3):301-310.
  • 4CAMPOCHIARO PA. Ocular neovascularization and excessivevascular permeability [ J ]. Expert Opin Biol Ther,2004,4(9):1395-1402.
  • 5OZAKI H , HAYASHI H , VINORES SA,MOROMIZATO Y, CAM-POCHIARO PA, OSHIMA K. Intravitreal sustained release ofVEGF causes retinal neovascularization in rabbits and break-down of the blood-retinal barrier in rabbits and primates [ J ].Exp Eye fles,1997,64(4) :505-517.
  • 6NOMA H,FUNATSU H,MIMURA T,EQUCHI S,HORI S. Sol-uble vascular endothelial growth factor receptor-2 and in-flammatory factors in macular edema with branch retinalvein occlusion[ J]. Am J Ophthalmol,2011,152 (4) :669-677.e1.
  • 7MICHELS S,ROSENFELD PJ, PULIAFITO CA,MARCUS EN,VENKATRAMAN AS. Systemic Bevacizumab (Avastin) thera-py for neovascular age-related macular degeneration : twelve-week results of an uncontrolled open-label clinical study [J] .Ophthalmology,2005 ,112(6) : 1035-1047.
  • 8EPSTEIN DL,ALGVERE PV,VON WENDT G, SEREGARD S,KVANTA A. Bevacizumab for macular edema in central reti-nal vein occlusion : a prospective, randomized, double-masked clinical study [ J]. Ophthalmology, 2012, 119: 1184-1189.
  • 9EPSTEIN DL,ALGVERE PV,VON WENDT G,SEREGARD S,KVANTA A. Benefit from bevacizumab for macular edema incentral retinal vein occlusion : twelve-month results of a pro-spective ,randomized study [ J]. Ophthalmology, 2012,119:2587-2591.
  • 10RAMEZANI A, ESFANDIARI H,ENTEZARI M, MORADIANS,SOHEILIAN M,DEHSARVI B,et al. Three intravitreal bev-acizumab versus two intravitreal triamcinolone iyyections inrecent-onset branch retinal vein occlusion[ J]. Graefes ArchClin Exp2012,250(8) :1149-1160.

二级参考文献24

  • 1喻晓兵,戴虹,龙力.玻璃体腔曲安奈德注射联合黄斑格栅样光凝治疗糖尿病性弥漫性黄斑水肿[J].中国实用眼科杂志,2007,25(10):1088-1089. 被引量：10
  • 2Pitcher JD 3rd,Liu T,Prasad PS,et al.Short-duration focal pattern grid photocoagulation for macular edema secondary to branch retinal vein occlusion[J].Semin Ophthalmol,2012,27(3-4):69-72.
  • 3Finkelstein D.Argon laser photocoagulation for macular edema in branch vein occlusion[J].Ophthalmology,1986,93(7):975-977.
  • 4Noma H,Funatsu H,Yamasaki M,et al.Pathogenesis of macular edema with branch retinal vein occlusion and intraocular levels of vascular endothelial growth factor and interleukin-6[J].Am J Ophthalmol,2005,140(2):256-261.
  • 5Hirashima T,Chihara T,Bun T,et al.Intravitreal bevacizumab alone or combined with macular laser photcoagulation for recurrent or persistent macular edema secondary to branch retinal vein occlusion[J/OL].J Ophthalmol,2014,2014:173084[2014-07-07].http://www.ncbi.nlm.nih.gov/pmc/articles/ PMC4119681/pdf/JOPH2014-173084.pdf.
  • 6Tan MH,McAllister IL,Gillies ME,et al.Randomized controlled trial of intravitreal ranibizumab versus standard grid laser for macular edema following branch retinal vein occlusion[J].Am J Ophthalmol,2014,157(1):237-247.
  • 7Chen CH,Chen YH,Wu PC,et al.Treatment of branch retinal vein occlusion induced macular edema in treatment-nmve cases with a single intravitreal triamcinolone or bevacizumab injection[J].Chang Gung Med J,2010,33(4):424-435.
  • 8Feng J,Zhao T,Zhang Y,et al.Differences in aqueous concentrations of cytokines in macular edema secondary to branch and central retinal vein occlusion[J/OL].PLoS One,2013,8(7):E68149[2013-07-05].http://www.ncbi.nlm.nih.gov/pmc/articles /PMC3702559/ pdf/pone.0068149.pdf.
  • 9Yoshimura T,Sonoda KH,Sugahara M,et al.Comprehensive analysis of inflammatory immune mediators in vitreoretinal diseases[J/OL].Plos One,2009,4(12):8158[2009-12-09].http://www.ncbi.nlm.nih.gov/pmc/articles /PMC2780733 / pdf/pone.0008158.pdf.
  • 10Pfister M,Rothweiler F,Michaelis M,et al.Correlation of inflammatory and proangiogenic cytokines from undiluted vitreous samples with spectral domain OCT scans,in untreated branch retinal vein occlusion[J].Clin Ophthalmol,2013,7:1061-1067.

共引文献121

同被引文献243

引证文献32

二级引证文献165

眼科新进展
2016年 第11期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
关于我们 | 版权声明 | 联系我们 | 帮助中心| 意见反馈
主办单位：上海市教育委员会
技术支持：重庆维普资讯有限公司
渝公网安备 50019002500403号
使用帮助 返回顶部